
CAS 960226-55-5
:Formule :C22H19N3O4
InChI :InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1/i1D3
Code InChI :WOXKDUGGOYFFRN-WFMNTJQSSA-N
SMILES :[2H]C([2H])([2H])N1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
7 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
Tadalafil-d3
CAS :Formule :C22H16D3N3O4Couleur et forme :White To Off-White SolidMasse moléculaire :392.43(6R,12aR)-Tadalafil-d3 (N-methyl-d3)
CAS :Degré de pureté :99 atom % DCouleur et forme :White To Off White SolidMasse moléculaire :392.43Tadalafil-D3
CAS :Tadalafil-D3 is a deuterated compound of Tadalafil. Tadalafil (T1398) has a CAS number of 171596-29-5. Tadalafil (T1398) is a carboline-based compound with vasodilatory activity. Tadalafil (T1398) selectively inhibits the cyclic guanosine monophosphate (cGMP)-specific type 5 phosphodiesterase- (PDE-5)-mediated degradation of cGMP, which is found in the smooth muscle of the corpus cavernosa and corpus spongiosum of the penis. Inhibition of cGMP degradation by tadalafil results in prolonged muscle relaxation, vasodilation, and blood engorgement of the corpus cavernosa, and, so, prolonged penile erection.Formule :C22H19N3O4Masse moléculaire :392.4224Tadalafil-d3
CAS :Produit contrôléStability Unstable in Methanol
Applications Tadalafil is used for the treatment of erectile dysfunction. A phosphodiesterase 5 inhibitor.
References Carrier, S., et al.: Can. J. Urol., 10(1), 12 (2003), Doggrell, S.A., et al.: Expert Opin. Pharmacother., 6, 75 (2005), Forgue, S.T., et al.: Br. J. Clin. Pharmacol., 61, 280 (2005),Formule :C222H3H16N3O4Couleur et forme :NeatMasse moléculaire :392.42







